Explore our CPTAC Pan-Cancer Studies papers! These exciting studies illuminate shared and distinct aspects of tumor biology and collectively showcase the value of investigating cancer through a proteogenomic lens. https://t.co/NFNZnpiTWg
Researchers at #WashUMed, @broadinstitute of @MIT and @Harvard, @BYU and more have completed an analysis of the proteins driving cancer across multiple tumor types. This raises the prospect of new therapies that block key proteins that drive cancer growth. https://t.co/VycjVYgzd7
In three new pan-cancer studies, #CPTAC researchers have harmonized data on proteins, DNA, and RNA, together with clinical data from more than 1,000 patients to uncover ways in which proteins are involved in important cancer processes. https://t.co/PCcfH9e25Z
Super excited to share with you the results of the CPTAC PanCancer Driver project, today officially out at @cellcellpress!
https://t.co/qGN3KBeu4d
Here’s a short tweetorial with the main findings where our lab mostly contributed
Today Cell, Cancer Cell and Cell Reports Medicine are pleased to publish the 1st wave of Pan-#Cancer multiomics papers looking at over 1000 patients across 10 #tumor types from @theNCI Clinical Proteomic Tumor Analysis Consortium #CPTAC (1/n) @Cancer_Cell@CellRepMed#openaccess